Alterations of tumor microenvironment by nitric oxide impedes castration-resistant prostate cancer growth

Immune targeted therapy of nitric oxide (NO) synthases are being considered as a potential frontline therapeutic to treat patients diagnosed with locally advanced and metastatic prostate cancer. However, the role of NO in castration-resistant prostate cancer (CRPC) is controversial because NO can in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Proc Natl Acad Sci U S A
Main Authors: Arora, Himanshu, Panara, Kush, Kuchakulla, Manish, Kulandavelu, Shathiyah, Burnstein, Kerry L., Schally, Andrew V., Hare, Joshua M., Ramasamy, Ranjith
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2018
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217394/
https://ncbi.nlm.nih.gov/pubmed/30322928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1812704115
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados